0
Skip to Content
HEPSANET
About
Epidemiology
Preventing mother to child transmission
Antiviral treatment for chronic hepatitis B
Patient education and awareness
Projects
Biomarkers
Longitudinal study
Our team
Our Team
Addis Ababa, Ethiopia
Cape Town, South Africa
Dakar, Senegal
Karonga and Lilongwe, Malawi
Khartoum, Sudan
Lusaka, Zambia
Ouagadougou, Burkina Faso
Stellenbosch, South Africa
UTH Bogodogo, Ougagdougou
Jos, Nigeria
Kumasi, Ghana
Our Vision
Publications
Funding
Data
News
HEPSANET
About
Epidemiology
Preventing mother to child transmission
Antiviral treatment for chronic hepatitis B
Patient education and awareness
Projects
Biomarkers
Longitudinal study
Our team
Our Team
Addis Ababa, Ethiopia
Cape Town, South Africa
Dakar, Senegal
Karonga and Lilongwe, Malawi
Khartoum, Sudan
Lusaka, Zambia
Ouagadougou, Burkina Faso
Stellenbosch, South Africa
UTH Bogodogo, Ougagdougou
Jos, Nigeria
Kumasi, Ghana
Our Vision
Publications
Funding
Data
News
Folder: About
Back
Epidemiology
Preventing mother to child transmission
Antiviral treatment for chronic hepatitis B
Patient education and awareness
Folder: Projects
Back
Biomarkers
Longitudinal study
Folder: Our team
Back
Our Team
Addis Ababa, Ethiopia
Cape Town, South Africa
Dakar, Senegal
Karonga and Lilongwe, Malawi
Khartoum, Sudan
Lusaka, Zambia
Ouagadougou, Burkina Faso
Stellenbosch, South Africa
UTH Bogodogo, Ougagdougou
Jos, Nigeria
Kumasi, Ghana
Our Vision
Publications
Funding
Data
News
  • Cohort description

    EPIDEMIOLOGY AND INFECTION 2023

    This paper describes the HEPSANET cohort baseline data and sets out the research vision for the network.

    Read paper
  • Biomarkers for liver fibrosis

    NATURE COMMUNICATIONS 2023

    We investigated the performance of non-invasive markers for liver fibrosis in Africa, testing APRI, GPR and ALT. We derived new thresholds with improved performance.

    Read paper
  • Perspective: challenges for HBV in Africa

    BMC GLOBAL AND PUBLIC HEALTH 2023

    This perspective article set out the challenges in care for people with HBV in Africa and suggested how we can work to improve it.

    Read paper
  • HEPSANET score for treatment eligiblity

    LANCET GASTROENTEROLOGY AND HEPATOLOGY 2024

    We developed a score that can be used in rural and decentralised settings for determining treatment eligibility using data from the HEPSANET cohorts

    Read paper

HEPSANET: Hepatitis B in Africa Collaborative Network